Epidural analgesia and avoidance of blood transfusion are associated with reduced mortality in patients with postoperative pulmonary complications following thoracotomic esophagectomy: a retrospective cohort study of 335 patients.
Analgesia, Epidural
/ statistics & numerical data
Blood Transfusion
/ statistics & numerical data
Esophagectomy
/ adverse effects
Female
Germany
/ epidemiology
Humans
Incidence
Lung Diseases
/ epidemiology
Male
Middle Aged
Postoperative Complications
/ mortality
Retrospective Studies
Risk Factors
Thoracotomy
/ adverse effects
90-days mortality
Blood transfusion
Esophagectomy
Independent risk factors
Postoperative pulmonary complications
Thoracic epidural anesthesia
Journal
BMC anesthesiology
ISSN: 1471-2253
Titre abrégé: BMC Anesthesiol
Pays: England
ID NLM: 100968535
Informations de publication
Date de publication:
22 08 2019
22 08 2019
Historique:
received:
29
01
2019
accepted:
18
08
2019
entrez:
24
8
2019
pubmed:
24
8
2019
medline:
18
6
2020
Statut:
epublish
Résumé
Postoperative pulmonary complications (PPCs) represent the most frequent complications after esophagectomy. The aim of this study was to identify modifiable risk factors for PPCs and 90-days mortality related to PPCs after esophagectomy in esophageal cancer patients. This is a single center retrospective cohort study of 335 patients suffering from esophageal cancer who underwent esophagectomy between 1996 and 2014 at a university hospital center. Statistical processing was conducted using univariate and multivariate stepwise logistic regression analysis of patient-specific and procedural risk factors for PPCs and mortality. The incidence of PPCs was 52% (175/335) and the 90-days mortality rate of patients with PPCs was 8% (26/335) in this study cohort. The univariate and multivariate analysis revealed the following independent risk factors for PPCs and its associated mortality. ASA score ≥ 3 was the only independent patient-specific risk factor for the incidence of PPCs and 90-days mortality of patients with an odds ratio for PPCs being 1.7 (1.1-2.6 95% CI) and an odds ratio of 2.6 (1.1-6.2 95% CI) for 90-days mortality. The multivariate approach depicted two independent procedural risk factors including transfusion of packed red blood cells (PRBCs) odds ratio of 1.9 (1.2-3 95% CI) for PPCs and an odds ratio of 5.0 (2.0-12.6 95% CI) for 90-days mortality; absence of thoracic epidural anesthesia (TEA) revealed the highest odds ratio 2.0 (1.01-3.8 95% CI) for PPCs and an odds ratio of 3.9 (1.6-9.7 95% CI) for 90-days mortality. In esophageal cancer patients undergoing esophagectomy via thoracotomy, epidural analgesia and the avoidance of intraoperative blood transfusion are significantly associated with a reduced 90-days mortality related to PPCs.
Sections du résumé
BACKGROUND
Postoperative pulmonary complications (PPCs) represent the most frequent complications after esophagectomy. The aim of this study was to identify modifiable risk factors for PPCs and 90-days mortality related to PPCs after esophagectomy in esophageal cancer patients.
METHODS
This is a single center retrospective cohort study of 335 patients suffering from esophageal cancer who underwent esophagectomy between 1996 and 2014 at a university hospital center. Statistical processing was conducted using univariate and multivariate stepwise logistic regression analysis of patient-specific and procedural risk factors for PPCs and mortality.
RESULTS
The incidence of PPCs was 52% (175/335) and the 90-days mortality rate of patients with PPCs was 8% (26/335) in this study cohort. The univariate and multivariate analysis revealed the following independent risk factors for PPCs and its associated mortality. ASA score ≥ 3 was the only independent patient-specific risk factor for the incidence of PPCs and 90-days mortality of patients with an odds ratio for PPCs being 1.7 (1.1-2.6 95% CI) and an odds ratio of 2.6 (1.1-6.2 95% CI) for 90-days mortality. The multivariate approach depicted two independent procedural risk factors including transfusion of packed red blood cells (PRBCs) odds ratio of 1.9 (1.2-3 95% CI) for PPCs and an odds ratio of 5.0 (2.0-12.6 95% CI) for 90-days mortality; absence of thoracic epidural anesthesia (TEA) revealed the highest odds ratio 2.0 (1.01-3.8 95% CI) for PPCs and an odds ratio of 3.9 (1.6-9.7 95% CI) for 90-days mortality.
CONCLUSION
In esophageal cancer patients undergoing esophagectomy via thoracotomy, epidural analgesia and the avoidance of intraoperative blood transfusion are significantly associated with a reduced 90-days mortality related to PPCs.
Identifiants
pubmed: 31438866
doi: 10.1186/s12871-019-0832-5
pii: 10.1186/s12871-019-0832-5
pmc: PMC6706927
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
162Références
Dis Esophagus. 2010 Sep;23(7):523-8
pubmed: 20459444
Int J Clin Exp Pathol. 2013 Dec 15;7(1):272-9
pubmed: 24427348
J Thorac Cardiovasc Surg. 2002 Apr;123(4):661-9
pubmed: 11986593
Langenbecks Arch Surg. 2015 Jan;400(1):19-26
pubmed: 25240610
Arch Surg. 2008 Oct;143(10):990-9; discussion 1000
pubmed: 18936379
J Am Coll Surg. 2006 Mar;202(3):395-400
pubmed: 16500242
Anesth Analg. 2016 Jan;122(1):186-93
pubmed: 26418125
Int J Surg. 2014 Dec;12(12):1500-24
pubmed: 25046751
Ann Thorac Surg. 2002 Mar;73(3):922-6
pubmed: 11899202
Semin Cardiothorac Vasc Anesth. 2014 Mar;18(1):36-44
pubmed: 23719773
Surg Today. 2019 Feb;49(2):176-186
pubmed: 30255330
Ann Surg. 2015 Jul;262(1):79-85
pubmed: 24979602
Ann Surg. 2001 Mar;233(3):338-44
pubmed: 11224620
Ann Surg. 2004 Nov;240(5):791-800
pubmed: 15492560
Int J Surg. 2010;8(1):58-63
pubmed: 19897061
Ann Thorac Surg. 2011 May;91(5):1494-1500; discussion 1500-1
pubmed: 21524462
World J Surg. 2018 Jan;42(1):204-210
pubmed: 28741191
Dis Esophagus. 2018 May 1;31(5):
pubmed: 29211841
J Surg Res. 2009 May 1;153(1):114-20
pubmed: 19201421
Ann Surg. 2018 May;267(5):886-891
pubmed: 28338513
Ann Surg Oncol. 2011 May;18(5):1460-8
pubmed: 21184193
Dis Esophagus. 2019 Mar 1;32(3):
pubmed: 30239639
J Gastrointest Surg. 2017 Nov;21(11):1757-1763
pubmed: 28900830
Br J Anaesth. 2017 Oct 1;119(4):655-663
pubmed: 29121283
Surg Endosc. 2018 Jan;32(1):204-211
pubmed: 28643075
Ann Surg. 2011 Dec;254(6):894-906
pubmed: 21785341
BMC Anesthesiol. 2017 Dec 4;17(1):164
pubmed: 29202701
World J Surg. 2017 Jan;41(1):208-215
pubmed: 27730355
Ann Surg. 2015 Aug;262(2):286-94
pubmed: 25607756
J Cardiothorac Vasc Anesth. 2012 Aug;26(4):569-74
pubmed: 22336690
Dis Esophagus. 2017 Oct 1;30(10):1-11
pubmed: 28859388
Int J Mol Med. 2014 Jul;34(1):137-44
pubmed: 24788377
BMC Surg. 2017 Jan 13;17(1):6
pubmed: 28086855
PLoS One. 2016 Apr 25;11(4):e0154380
pubmed: 27110939
J Surg Oncol. 2004 Nov 1;88(2):71-7
pubmed: 15499604
Dis Esophagus. 2015 Nov-Dec;28(8):797-804
pubmed: 25327623